Nervgen Pharma

NGENNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$140.550 M

$1.71 -0.58%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

79,649,257

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#284Canton StrategicCNTN$144.2M
#285ADC TherapeuticsADCT$143.7M
#286Nervgen PharmaNGEN$140.6M
#287Organigram GlobalOGI$139.4M
#288vTv TherapeuticsVTVT$139.3M

Where these numbers come from

Share counts and financials for Nervgen Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.